SRX Global is trading 5.29% higher at $1.79 after announcing liquidations of its investments in Vistagen Therapeutics and Greenland Mines, alongside a new investment in Onconetix. - Onconetix plans to acquire Realbotix, whose technology is AI-enabled and robotic. - Broader markets were modestly lower on September 24, 2026.